At Neogen, we believe that protecting your facility’s cleanliness is essential for operational excellence. Our Clean-Trace® ATP Monitoring System verifies the effectiveness of cleaning protocols by accurately detecting organic residue on surfaces. | For companies committed to safeguarding the food supply, reducing risk, and boosting testing efficiency, Count on Neogen. Our trusted solutions and expert team help you get ahead of potential food safety issues that could impact your products—and your brand. Streamline your environmental monitoring, simplify lab workflows, reduce variability, and deliver rapid, reliable test results. Together, we help protect your business, your customers, and the world you nourish. | Neogen develops and markets comprehensive solutions dedicated to food and animal safety. Neogen is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, rodent and insect control solutions. | When you’re a leader in food safety and food security you understand the importance of clean water. For over 40 years Neogen has made it our mission to develop testing solutions that are easy and reliable. Our range of water treatment solutions provide effective results to help enable safe drinking water for the public. Our team of experts is available to assist you with any of our solutions, like Colitag™, which offers accurate results for total coliform and E. coli. | Neogen provides a comprehensive range of solutions and services for the food processing, animal protein and agriculture industries, not only helping to protect the world’s food supply, but also enabling our customers to produce more efficiently and effectively than they could before.
NASPO ValuePoint
NASPO ValuePoint is the cooperative purchasing division of the National Association of State Procurement Officials (NASPO), facilitating cooperative public procurement solicitations using a Lead State Model™. NASPO aggregates the demand of all 50 states, the District of Columbia, the US territories, their political subdivisions, and other eligible entities, spurring best value, innovation, and competition in the marketplace. NASPO ValuePoint delivers high-value, reliable, and competitively sourced cooperative contracts – offering public entities outstanding prices, favorable terms and conditions, and value-added services.NASPO ValuePoint Master Agreement are competitively solicited using NASPO ValuePoint’s Lead State Model™ brand services, supported by our Multistate Sourcing Team™ comprised of multiple state procurement representatives and subject matter experts; leveraging the expertise and buying power of the many states and other participating entities. Contact us to engage the power of our Lead State Model™ brand cooperative negotiation and purchasing services. | NASPO ValuePoint is the cooperative purchasing division of the National Association of State Procurement Officials, facilitating cooperative public procurement using a Lead State Model™. NASPO aggregates the demand of all 50 states, the District, US territories, and eligible entities, spurring best value and competition in the marketplace.
NASPO ValuePoint
NASPO ValuePoint is the cooperative purchasing division of the National Association of State Procurement Officials (NASPO), facilitating cooperative public procurement solicitations using a Lead State Model™. NASPO aggregates the demand of all 50 states, the District of Columbia, the US territories, their political subdivisions, and other eligible entities, spurring best value, innovation, and competition in the marketplace. NASPO ValuePoint delivers high-value, reliable, and competitively sourced cooperative contracts – offering public entities outstanding prices, favorable terms and conditions, and value-added services.NASPO ValuePoint Master Agreement are competitively solicited using NASPO ValuePoint’s Lead State Model™ brand services, supported by our Multistate Sourcing Team™ comprised of multiple state procurement representatives and subject matter experts; leveraging the expertise and buying power of the many states and other participating entities. Contact us to engage the power of our Lead State Model™ brand cooperative negotiation and purchasing services. | NASPO ValuePoint is the cooperative purchasing division of the National Association of State Procurement Officials, facilitating cooperative public procurement using a Lead State Model™. NASPO aggregates the demand of all 50 states, the District, US territories, and eligible entities, spurring best value and competition in the marketplace.
Mote Therapeutics
We are a seed-stage biotech solving targeted delivery of mRNA-based medicines. mRNA has achieved breakthrough success with COVID vaccines, but access to most disease-relevant tissues and cell types remains an unresolved challenge with current mRNA delivery systems. Engineering next-generation delivery systems therefore holds enormous promise for expanding the application space of mRNA into novel therapeutic areas. A new wave of mRNA delivery-focused companies such as Capstan and Aera Therapeutics have entered this exciting space with targeted delivery solutions that lack modularity or are very challenging to scale. At Mote, we have created the Mobilize technology platform: a scalable, modular, and effective LNP based targeted mRNA delivery solution proven in vivo (in mice and NHP) to both actively target nanoparticles to cells of interest and prevent uptake in unintended targets. Some basic facts about us: 1. Our founder, Dr. Alex Wesselhoeft invented the circular RNA technology and cofounded Orna before he started Mote. 2. Founded in 2023 Q2, we have two fully operational locations: one in Massachusetts, USA and one in Guangdong, China, combining the advantages of both locales. 3. We hold patent filings covering our key technology innovations and are expanding into adjacent areas. 4. We are looking for interested parties to expand the horizon of mRNA medicines together, through direct investment, partnership, or platform licensing.
Medicilon
Medicilon offers fully integrated pharmaceutical services for global scientific community, focusing on providing exceptional client-centered experience and advancing your candidates through the drug discovery process.Our integrated services across biology, chemistry and preclinical services are designed to help clients developing their R&D programs from initial idea stage to IND filing phase. | Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com.
Medicilon
Medicilon offers fully integrated pharmaceutical services for global scientific community, focusing on providing exceptional client-centered experience and advancing your candidates through the drug discovery process.Our integrated services across biology, chemistry and preclinical services are designed to help clients developing their R&D programs from initial idea stage to IND filing phase. | Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com.
Medicilon USA Corp
Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. From drug discovery, pharmaceutical research to preclinical research, Medicilon has supported more than 2000 client R&D programs worldwide resulting in 520 IND filings. With proven scientific excellence and FDA-aligned methodologies, we help biotech and pharmaceutical innovators fast-track their path from discovery to IND success. | Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. Medicilon has 21 years experience in the industry and has supported more than 2000 client R&D programs worldwide resulting in 580 IND filings. The company has over 441,320 ft2 of chemistry labs with > 1300 chemists located at three different sites. With operations in the USA, China, and Europe, Medicilon is a leading CRO offering integrated pharmaceutical R&D services, including DMPK/PD, toxicology (GLP and non-GLP), chemistry, discovery biology, and CMC research. In addition, Medicilon offers attractive large animal models (non-human primates, dogs, rabbits, and miniature pigs), tumor & non-tumor animal models (including Xenograft models, PDX / PDXO models), and support for simultaneous U.S. IND filing to streamline global drug development and approval.
Medicilon USA Corp
Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. From drug discovery, pharmaceutical research to preclinical research, Medicilon has supported more than 2000 client R&D programs worldwide resulting in 520 IND filings. With proven scientific excellence and FDA-aligned methodologies, we help biotech and pharmaceutical innovators fast-track their path from discovery to IND success. | Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. Medicilon has 21 years experience in the industry and has supported more than 2000 client R&D programs worldwide resulting in 580 IND filings. The company has over 441,320 ft2 of chemistry labs with > 1300 chemists located at three different sites. With operations in the USA, China, and Europe, Medicilon is a leading CRO offering integrated pharmaceutical R&D services, including DMPK/PD, toxicology (GLP and non-GLP), chemistry, discovery biology, and CMC research. In addition, Medicilon offers attractive large animal models (non-human primates, dogs, rabbits, and miniature pigs), tumor & non-tumor animal models (including Xenograft models, PDX / PDXO models), and support for simultaneous U.S. IND filing to streamline global drug development and approval.
Link-Belt Excavators
For over 150 years, Link-Belt has built a legacy of innovation and reliability. Today, LBX Company proudly carries that tradition forward as the maker of Link-Belt excavators, scrap and material handlers, and forestry equipment. We’re showcasing our latest machines, advanced technology and jobsite solutions, all designed to make your work easier, safer and more productive.